Elevance Health (ELV) FY2016 results: revenue $84.9 billion, up 7.2% on the year
Elevance Health, Inc. (ELV) reported revenue of $84.9 billion for fiscal 2016, the year ended 31 December 2016, up 7.2% on the year before. Net income was $2.5 billion, down 3.5%, and diluted earnings per share $9.21. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2017.
Revenue
$84.9 billion
+7.2% on the year
FY2009FY2016
Operating margin
5.7%
6.0% a year earlier
FY2009FY2016
Net income
$2.5 billion
-3.5% on the year
FY2009FY2016
Diluted EPS
$9.21
-1.8% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
84,863
79,156
73,874
+7.2%
Selling, general and administrative
12,558
12,535
11,748
+0.2%
Operating income
4,802
4,753
4,418
+1.0%
Operating margin
5.7%
6.0%
6.0%
Interest expense
723
653
601
+10.7%
Pre-tax income
4,555
4,631
4,368
-1.6%
Income tax
2,086
2,071
1,808
+0.7%
Effective tax rate
45.8%
44.7%
41.4%
Net income
2,470
2,560
2,570
-3.5%
Net margin
2.9%
3.2%
3.5%
Diluted EPS
$9.21
$9.38
$8.99
-1.8%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
3,270
4,212
3,369
-22.4%
Capital expenditure
584
638
715
-8.6%
Free cash flow
2,686
3,574
2,655
-24.8%
Free cash flow margin
3.2%
4.5%
3.6%
Cash from investing
-514
-1,152
-975
Cash from financing
-799
-3,093
-1,822
Depreciation and amortisation
296
336
327
-11.8%
Share-based compensation
165
148
169
+11.3%
Buybacks
0.0
1,516
2,999
Dividends paid
684
657
481
+4.2%
Dividend per share
$2.60
$2.50
$1.75
+4.0%
Diluted shares, weighted
268m
273m
286m
-1.8%
Shares outstanding at period end
264m
261m
268m
+1.0%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
25,100
23,044
24,251
+8.9%
Debt
15,727
15,864
15,044
-0.9%
Other liabilities
24,256
22,809
22,381
+6.3%
Total liabilities and equity
65,083
61,718
61,676
+5.5%
Fixed assets
1,978
2,020
1,944
-2.1%
Goodwill
17,561
17,562
17,082
-0.0%
Intangible assets
7,965
8,158
7,958
-2.4%
Investments
17,688
17,478
17,972
+1.2%
Cash and equivalents
4,075
2,114
2,152
+92.8%
Other assets
15,816
14,386
14,568
+9.9%
Total assets
65,083
61,718
61,676
+5.5%
10-K for the year ended 31 December 2016, filed 22 February 2017: the filing.